Diabetes - Market Outlook & Scenario Planning

• Learn how current & future diabetes market dynamics will impact on sales of antidiabetics.
• Know your future competition: pipeline analysis and forecasts of key developmental compounds.
• Participate in a scenario planning workshop focused on the diabetes market and learn how to conduct such session in your own company to better plan the future.
  
• Identify the critical success factors to compete successfully in the diabetes market.
  
• Benefit from interacting with market analysts and your peers in a focused workshop.

 

What sets this course apart?

The faculty: In Europe, Datamonitor is the only business intelligence company with a team of diabetes market analysts dedicated to analyzing unmet medical need, epidemiological trends, therapeutic algorithms, pipelines, and capable of projecting sales forecasts of current and emerging diabetes compounds on that basis. These seminars offer a unique opportunity to closely interact with Datamonitor’s lead analysts.

The content: Datamonitor shares the best of their research with you in this seminar. You will be exposed to the most valuable information and insights that their analysts have published and you will be able to process this information during a truly unique scenario planning workshop, led by Datamonitor’s scenario planning expert – unique, indeed, because you will be working with your peers in the industry.

Who should attend?

Anyone involved in the marketing of current and late stage development antidiabetics.

Past participants

Market Access Manager	AstraZeneca	Netherlands
Market Research Manager Oncology	Bayer Schering Pharma	Germany
Global Brand Manager	Bayer Schering Pharma	Deutschland
Market Manager Europe	Becton Dickinson	France
Head of Cdept. Customer Group Urologist /Oncologists	Boehringer Ingelheim	Germany
Senior Project Manager - Oncology	Chugai	UK	Testimonial
CSO, VP	Egalet	Denmark
Head of Strategy & Commercial Analysis	GlaxoSmithKline	France
Head of Marketing Intelligence	Janssen-Cilag	UK
New Product Development Director	Johnson & Johnson	USA
International Product Manager	Novo Nordisk	Denmark
Product Manager	Novo Nordisk	Netherlands
Senior Director / Group Leader	Pfizer	USA
Oncology Business Analyst	Roche	UK
Medical Manager	Sanofi-aventis	Belgium	Testimonial
Market Research Specialist	Sanofi-aventis	Belgium
Vice President NPC CNS	UCB	Belgium
Director New Product Commercialization CNS	UCB	Belgium	Testimonial

Programme outline

You are welcome to join us for the welcome coffee at 9:30. The actual programme starts at 10:00 and closing will be no later than 17:00.

09:30 - 10:00	Welcome Coffee
10:00 - 10:15	Introductions
10:15 - 11:00	Dynamics & Commercial Outlook of the Diabetes Market Dr. Nick Karachalias Current market trends and dynamics Commercial opportunities and threats Key players in the diabetes field Lifecycle management strategies Market forecasts up to 2017 Assumptions and events expected to shape the market Strategic recommendations and conclusions
11:00 – 11:15	Coffee Break
11:15 – 12:15	Pipeline Status & Forecasts of Pipeline Compounds Dr. Anthony Nealon Pipeline overview of developmental agents for the treatment of diabetes Mechanism of action of promising developmental compounds Detailed analysis of key agents in development Forecasts of key emerging compounds up to 2017
12:15 – 13:00	Lunch
13:00 – 13:45	Introduction to the Scenario Planning Workshop Christine Hickey  What is scenario planning - what are the benefits of doing it? When is it appropriate to conduct a scenario planning engagement? Tools, techniques and methodologies for successful scenario planning
13:45 – 16:15	Scenario Planning Workshop for the Diabetes Market This interactive session will allow the audience to transform key market data and insights, as presented in the morning, into a better understanding of market dynamics and critical success factors. Starting from a fictitious (but realistic) product profile, you will discuss within a group of max. 8 participants what it takes to successfully launch and market an anti-diabetic in a market facing the challenges that your product(s) will also face. As a result of this creative process, you will be able to: Identify the critical factors that your diabetes product or portfolio must achieve in order to succeed in the future. More effectively design plans (both strategic and tactical) required to achieve these success factors. Ensure your company’s diabetes marketing teams monitor the critical uncertainties and risks for which they should contingency plan. In addition, by undertaking this exercise, you will learn about the tools and techniques applied in scenario planning, understand the benefits of this process and when to use it, and appreciate how scenario planning enables you to plan for success despite the unpredictable nature of the future. (A 15 minute coffee break is scheduled at 15:00)
16:15 – 16:45	Q&A and Closing Remarks

Meet the experts:

Dr. Nick Karachalias

• Lead Analyst for Datamonitor’s diabetes & cardiovascular disease business team providing in-depth market analysis and insight.
• Developed and successfully led several Diabetes Market Outlook seminars with C.E.L.forpharma since 2006.
• Formerly Senior Research Officer, University of Essex.
• His PhD research (University of Essex, UK) focused on the prevention of the development of diabetic complications.

Anthony Nealon

• Senior Analyst for Datamonitor’s diabetes and cardiovascular business team providing in-depth market analysis and insight.
• Prior to joining Datamonitor Anthony worked within Intellectual Property for Thomson Scientific.
• His Doctorate (EngD) research (University College London, UK) focused on the scale-down of gene therapy bioprocess development in collaboration with GlaxoSmithKline.

Dr. Neal Hansen

• Global Director of Datamonitor’s Healthcare Consulting Practice
• Prior to this role, Neal was the European Head of Consulting within Wood Mackenzie’s Life Sciences Practice. During his time at Wood Mackenzie, Neal led commercial assessment, scenario planning and war gaming projects for numerous top tier and mid-cap pharmaceutical companies in Europe, the US and Japan.
  Earlier in his career, Neal held various senior roles within Datamonitor including Lead Consultant and Lead Analyst for Strategic and Company Intelligence encompassing Strategic Insight, eHealthInsight and PharmaVitae Company Tracking.
• He has authored in-depth analysis on strategic issues affecting the pharmaceutical industry, focusing on lifecycle management, pharmaceutical sales force strategies, competitive dynamics in mature and emerging markets and the changing nature of the global generics sector. He has chaired a spoken at numerous conferences in the field of lifecycle management and the changing nature of the generics industry. His work has featured in In Vivo, The Economist, The Wall Street Journal, MedAd News and PharmaFocus.
• Neal holds a PhD in Pharmacology (University of Cambridge), and a MA in Natural Sciences (University of Cambridge).

Dates

2009 date to be communicated

Venue & Accommodation

This course takes place at the Sheraton Airport Hotel & Conference Center which is situated in front of the Brussels National Airport, literally at 2 minutes walking distance from the arrival hall.

Sheraton Brussels Airport Hotel
Brussels National Airport
1930 Zaventem
Belgium
Tel: +32 (0) 2 710 80 00
Fax: +32 (0) 2 710 80 80

We have secured preferential room rates at this five star hotel for our delegates. Registering three weeks or more prior to the course will secure your room at a preferential rate. Upon your registration, you will receive from C.E.L.forpharma a Sheraton Brussels Airport Hotel Accommodation Sheet for you to complete and return by fax. Do not hesitate to contact Marie Stricklesse, Programme Coordinator, if you need assistance in this matter (marie.stricklesse@celforpharma.com ; tel +32(0)27092241)

 

Testimonials

Since every therapy market seminar organized with Datamonitor is unique, we can only provide a selection of testimonials received from past participants at previous seminars.

Very good 1-day seminar covering the main dynamics of the diabetes market for the coming years.

Eberhard Raemisch,  Senior Business Manager, Nycomed – Germany

This diabetes seminar was very well planned and executed in order to gain a maximum impact. Both the comprehensive market view and practical implementation on strategic planning and decisions will be applied by our company’s work post-programme.

Michael Renzo, New Business Development Director, J&J – USA

"The "Commercial Outlook of Key CNS markets" was an interesting symposium that gave a very good overview. I still use the slides regularly look into the handout, certainly when I need something quickly and I don't have the time to dig into the lengthy reports."

Sonja Buyle, Associate Director New Product Commercialization CNS, UCB - Belgium

"The seminar provided valuable insight into the likely future trends in the respiratory market, supported by excellent analyses from Datamonitor."

Will Heath, Director of Business Strategy, Napp Pharmaceuticals - United Kingdom

"A very pertinent and important seminar to those involved in the development of drugs for respiratory diseases. The information on market trends was very precisely put over and left no doubts as to which future developments will be of priority. The expert opinions by Prof. Tim Higenbottam and the other speakers were well received and gave much food for thought. It was also a nice opportunity to interact with both presenters and participants and the informal atmosphere made it very easy to achieve this. Overall, top marks."

Ken Mugridge, Drug Development Manager, Curacyte Discovery - Germany

"Excellent insight was provided with the analyses from Datamonitor.
A must have for anyone in a strategically important function!"

Jurgen De Beule, (Former) Medical Manager, Sanofi-aventis - Belgium

“C.E.L.forpharma provided a very interesting mix of business and scientific considerations in oncology drug development, enhanced by the excellent content, presentation and knowledge of the speakers. I found it a very useful and stimulating day.”

Keith Jones, Senior Project Manager, Chugai Pharma Europe Ltd. - UK

(go to top)